Abaloparatide and the Spine: A Narrative Review

Area of Science:

• Endocrinology
• Bone Biology
• Pharmacology

Background:

• Osteoporosis is a condition of diminished bone mass and architecture, leading to fragility.
• Antiresorptive medications are standard first-line osteoporosis treatments.
• Anabolic agents offer improved bone benefits over antiresorptive therapies.

Purpose of the Study:

• To review the mechanism, effects, and benefits of abaloparatide.
• To compare abaloparatide with alternative osteoporosis treatments.
• To discuss abaloparatide's impact on osteoporosis-related spinal complications.

Main Methods:

• Narrative review of current literature.
• Comparison of abaloparatide with bisphosphonates and teriparatide.
• Analysis of clinical trial data and pharmacological studies.

Main Results:

• Abaloparatide demonstrates significant anabolic effects on bone.
• It offers comparable or superior benefits to teriparatide in certain aspects.
• Evidence suggests efficacy in reducing vertebral fracture risk.

Conclusions:

• Abaloparatide represents a valuable anabolic option for osteoporosis management.
• Further research is ongoing to fully elucidate its long-term effects and comparative advantages.
• Its role in managing spinal osteoporosis complications warrants continued investigation.